Jack W. Singer
2011
In 2011, Jack W. Singer earned a total compensation of $1.2M as Interim Chief Medical Officer and Executive Vice President, Global Medical Affairs and Translational at CTI BioPharma, a 112% increase compared to previous year.
Compensation breakdown
| Bonus | $204,000 |
|---|---|
| Salary | $340,000 |
| Stock Awards | $649,836 |
| Other | $44,107 |
| Total | $1,237,943 |
Singer received $649.8K in stock awards, accounting for 52% of the total pay in 2011.
Singer also received $204K in bonus, $340K in salary and $44.1K in other compensation.
Rankings
In 2011, Jack W. Singer's compensation ranked 4,886th out of 10,747 executives tracked by ExecPay. In other words, Singer earned more than 54.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,886 out of 10,747 | 55th |
Division Manufacturing | 1,755 out of 3,960 | 56th |
Major group Chemicals And Allied Products | 369 out of 1,038 | 65th |
Industry group Drugs | 225 out of 786 | 71st |
Industry Pharmaceutical Preparations | 175 out of 571 | 69th |
Source: SEC filing on March 27, 2014.
Singer's colleagues
We found four more compensation records of executives who worked with Jack W. Singer at CTI BioPharma in 2011.